Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4160621000168112 | Cuvitru (normal immunoglobulin human 4 g / 20 mL) injection, 20 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4160631000168110 | Cuvitru 4 g/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cuvitru 4 g/20 mL injection, 20 mL vial | Is a | Cuvitru | true | Inferred relationship | Some | ||
| Cuvitru 4 g/20 mL injection, 20 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Cuvitru 4 g/20 mL injection, 20 mL vial | Is a | normal immunoglobulin 4 g/20 mL injection, vial | true | Inferred relationship | Some | ||
| Cuvitru 4 g/20 mL injection, 20 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Cuvitru 4 g/20 mL injection, 20 mL vial | has unit of use | vial | true | Inferred relationship | Some | 338838351 | |
| Cuvitru 4 g/20 mL injection, 20 mL vial | has intended active ingredient | normal immunoglobulin | true | Inferred relationship | Some | 338838350 | |
| Cuvitru 4 g/20 mL injection, 20 mL vial | has Australian BoSS | normal immunoglobulin | true | Inferred relationship | Some | 338838350 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cuvitru 4 g/20 mL injection, 20 mL vial | has TPUU | True | Cuvitru 4 g/20 mL injection, 20 mL vial | Inferred relationship | Some | 1 |
| Cuvitru 4 g/20 mL injection, 20 mL vial | has TPUU | True | Cuvitru 4 g/20 mL injection, 20 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR